Beschreibung
Clinical and preclinical evidence supporting astaxanthin supplementation for NAFLD management is compiled, with data from animal models and human trials indicating dose-dependent hepatoprotective benefits.
Cite This Figure
![Figure 6: Clinical and preclinical evidence supporting astaxanthin supplementation for NAFLD management is compiled, with data from animal models and human trials indicating dose-dependent hepatoprotective benefits.]() > Source: Nor Hafiza Sayuti et al. "Preventative and Therapeutic Effects of Astaxanthin on NAFLD.." *Antioxidants (Basel, Switzerland)*, 2023. PMID: [37627546](https://pubmed.ncbi.nlm.nih.gov/37627546/)
<figure> <img src="" alt="Clinical and preclinical evidence supporting astaxanthin supplementation for NAFLD management is compiled, with data from animal models and human trials indicating dose-dependent hepatoprotective benefits." /> <figcaption>Figure 6. Clinical and preclinical evidence supporting astaxanthin supplementation for NAFLD management is compiled, with data from animal models and human trials indicating dose-dependent hepatoprotective benefits.<br> Source: Nor Hafiza Sayuti et al. "Preventative and Therapeutic Effects of Astaxanthin on NAFLD.." <em>Antioxidants (Basel, Switzerland)</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37627546/">37627546</a></figcaption> </figure>